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SURGICAL TECHNIQUE___________________________________________________________
Preparation and Technical
Considerations for Percutaneous
Cannulation for Veno-Arterial
Extracorporeal Membrane Oxygenation
Kathleen M. Lamb, M.D., Hitoshi Hirose, M.D., and Nicholas C. Cavarocchi, M.D.
Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania
ABSTRACT Background: The most frequent limb complications from peripheral veno-arterial extracorporeal
membrane oxygenation (VA-ECMO) are limb ischemia and localized bleeding. To minimize these risks,
perfusion of the distal limb with peripheral percutaneous cannulation was done. Technique: Percutaneous
cannulation with a distal perfusion port was performed in all patients. During the VA-ECMO, distal limb
perfusion was monitored using near-infrared spectroscopy to assess tissue oxygenation. At the
decannulation, patch angioplasty was performed to prevent the development of narrowing of the artery
at the cannulation site. Conclusions: Using our standard technique, we have not experienced any limb loss
related to ischemia or bleeding. doi: 10.1111/jocs.12058 (J Card Surg 2013;28:190–192)
We describe our experience with percutaneous
femoral cannulation for veno-arterial (VA) extracorpore-
al membrane oxygenation circulation (ECMO) — both
preparation for and the technical aspects of this
procedure.
TECHNICAL DESCRIPTION
Percutaneous placement of femoral ECMO cannulas
can be done at any bedside in the hospital, intensive
care unit (ICU), emergency room, or catheterization lab,
or intra-operatively. This procedure is best performed
with two operators to control the cannulas and wires.
Before the procedure begins, both an upper extremity
central venous line and an arterial line must be inserted
for monitoring. After antibiotic administration, sterile
prep, and draping of entire body, placement of femoral
catheters begins with percutaneous puncture of the
femoral vein. Following Seldinger’s technique,1,2 a
flexible j-tip guidewire (0.038 inch  210 cm, Edwards
Lifesciences LLC, Irvine, CA, USA) is advanced from
the femoral vein into the inferior vena cava (IVC),
directed toward the right atrium. The ipsilateral or
contralateral femoral artery is punctured, with wire
advancement toward the aortic valve. The superficial
femoral artery (SFA) is accessedwith a 21 gaugemicro-
puncture needle, followed by a 0.018 inch nitinol wire
(CookMedical, Bloomington, IN, USA), directed toward
the foot, for distal perfusion catheter (DPC) placement
(Cook Medical; Fig. 1).3 After wire placement, a 5000–
7500 unit heparin bolus is administered to prevent
thrombosis in the cannulas. Cannulas are pre-selected
based on our experience and estimated patient sizes, as
measurements of vessel diameters are not typically
available. We attempt to use the largest cannula
feasible to minimize hemolysis. We refer to the
manufacturer pressure-flow curves for each cannula
size.1
The ECMO venous cannula (55 cm or 68 cm, 18–28
French, bio-compatible polyurethane, heparin-bonded,
Edwards Lifesciences LLC) is premeasured from the
femoral insertion site to a few centimeters below
the angle of Louis, approximating the mid-right atrium,
the ideal location for the tip of a venous cannula. Dilators
are serially placed over the venous guidewire until
access is appropriately enlarged, followed by place-
ment of the venous catheter over the wire. This is
advanced till the cannula tip is in the superior vena cava
near the right atrium (Fig. 2). The stylette and wire are
removed and the end of cannula is clamped. Dilators are
serially placed over the arterial guidewire, followed by
advancement of the arterial cannula (24 cm, 16–22
French, OptiSite Arterial Cannula, Edwards Lifescience
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LLC) into the iliac artery. The stylette and wire are
removed and end of the cannula clamped. A five or
seven FrenchDPC is placed over the SFAwire, after the
arterial catheter placement. The venous line is de-aired
and connected to the ECMO circuit. This is achieved by
application of a steady stream of normal saline to fill the
catheter, with forward flow of fluid from the circuit,
displacing any air. The circuit involves a Rotaflow
centrifugal pump (Maquet Cardiovascular LLC, San
Jose, CA, USA), and a Quadrox-D diffusion membrane
hollow-fiber oxygenator (Maquet Cardiovascular LLC).
The arterial line is subsequently de-aired and con-
nected. The arterial cannula side-port is connected with
6 inch extension tubing and a three-way stopcock to the
DPC, de-aired, and opened to reestablish flow into the
leg. It is imperative to examine the circuit for trapped air
prior to starting the circuit. Upon completion, all clamps
are removed; the patient is taken up to full flow of
approximately 4–5 L. The cannulas are secured to the
skin with sutures. Pericannula bleeding can be ad-
dressed by placement of hemostatic pads.4
This procedure can usually be performed within 30
minutes, with blood loss of only 100cc; however, it is
prudent to reserve two units of packed red blood cells.
Prophylactic antibiotics are continued for 24 hours.
Difficultly with cannulation seems related to pre-
existing peripheral vascular disease and overall small
vessel caliber.2 We initially will attempt to use a smaller
size cannula. Fluoroscopy may be a necessary adjunct
in these situations, rather than open cutdown, which
leads to persistent pericannula hemorrhage.
Our heparin protocol involves administration of a
bolus of 5000–7500 units after guidewire placement.
Heparin is held for 24 hours unless clots are observed in
the circuit. After 24 hours, an infusion is started with a
prothrombin time (PTT) therapeutic goal of 40–45
seconds; from day 2 onward, PTT goal is 45–55
seconds. We prefer to use PTT to monitor anti-
coagulation as activated clotting time (ACT), although
quick to obtain, is often unrealiable. We use heparin
bonded circuitry and continuously monitor our ECMO
circuitry and oxygenator for thrombi and change our
system if inappropriate oxygenation.
Consistent with our attempts to maintain limb
perfusion with DPC placement, the limb perfusion
should be monitored continually using the near-infrared
spectroscopy (NIRS).5 We are also able to monitor
cerebral perfusion using NIRS to avoid cerebral ische-
mia allowing wider application of percutaneous femoral
cannulation.
We recommend open repair when decannulating, as
unexpected bleeding, hematoma, pseudoaneurysm
or arteriovenous fistula may occur. This approach
also allows bovine pericardial patching if it appears
primary repair will lead to an area of stenosis. Prior
to decannulation, heparin drip was continued until
Figure 1. Percutaneous VA femoral ECMO guidewire access.
Figure 2. Percutaneous VA femoral ECMO cannulation.
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completion of repair of the vessels, avoiding cannula
clot formation. The venous cannulation site is closed
with purse string stitches, DPC site is closed primarily,
while the arterial site often requires bovine patch
angioplasty. Doppler examination and occasionally
Fogarty thrombectomy are necessary.
DISCUSSION
There are a variety of benefits derived from
percutaneous placement of ECMO cannulas including
ease of placement at the bedside in the ICU. Due to
heparinization while on ECMO, percutaneous access
decreases hemorrhage associated with open cannula-
tion, thus theoretically contributing to a decrease in
overall morbidity. We try to avoid single groin cannula-
tion, as in our experience bleeding complications tend
to be higher with single groin cannulation. Cannulas in
place for more than a few days leads to dilation of the
arteriotomy and venotomy, leading to persistent peri-
cannula hemorrhage and the need for ongoing transfu-
sion. Percutaneous placement reduces this complica-
tion due to smaller arteriotomy/venotomy than with
open techniques. At decannulation, open repair of the
vessel prevents bleeding and hematoma development
seen with percutaneous removal of catheters and
subsequent hemostasis with manual pressure. Open
repair of vessels also allows evaluation for potential
areas of stenosis and ability to perform patch angio-
plasty if needed.
Cannulation-related complications can occur in ap-
proximately 5% to 8%, in our experience of more than
100 percutaneous cannulations. These can include:
local bleeding from the femoral puncture or distal
perfusion cannula placement, dissection related with
cannula advancement or the inability to pass the venous
cannula due to clot formation from deep vein thrombo-
sis. In these situations, the opposite groin can be
accessed if necessary and bleeding controlled as
described.
The most significant complication as the result of
femoral cannulation is limb loss and ischemia. Preex-
isting peripheral vascular disease has been identified
as a risk factor for development of ischemia in both
percutaneous and open techniques.6 As such, known
severe peripheral vascular disease is one of our only
contraindications for femoral cannulation. Placement of
DPC,NIRSmonitoring, and patch closure of arteriotomy
scan help prevent complications of limb ischemia.
REFERENCES
1. Pranikoff T, Hirschl RB, Remenapp R, et al: Venovenous
extracorporeal life support via percutaneous cannulation in
94 patients. CHEST 1999;3:818–822.
2. Ganslmeier P, Philipp A, Repprecht L, et al: Percutaneous
cannulation for extracoporeal life support. Thorac Cardio-
vasc Surg 2011;59:103–107.
3. Sidebotham D, McGeorge A, McGuinness S, et al:
Emerging technology review: Extracoporeal membrane
oxygenation for treating severe cardiac and respira-
tory failure in adults: Part 2 - Technical considerations.
J Cardiothorac Vasc Anesth 2010;24(1):164–172.
4. Lamb KM, Pitcher HT, Cavarocchi NC, et al: Vascular site
hemostasis in percutaneous extracorporeal membrane
oxygenation therapy. Open Cardiovasc Thorac Surg J
2012;5:8–10.
5. Wong JK, Smith TN, Pitcher HT, et al: Cerebral and lower
limb near-infared spectroscopy in adults on extracorporeal
membrane oxygenation. Artif Organs 2012;36(8):659–
667.
6. Zimpfer D, Heinisch B, Czemy M, et al: Late vascular
complications after extracorporeal membrane oxygenation
support. Ann Thorac Surg 2006;81:892–895.
192 LAMB, ET AL. J CARD SURG
PREPARATION AND TECHNICAL CONSIDERATIONS FOR PERCUTANEOUS CANNULATION 2013;28:190–192
